Kynam Capital Management, LP 13D and 13G filings for Cullinan Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-03-04 3:16 pm Purchase | 2025-12-31 | 13G | CULLINAN THERAPEUTICS INC CGEM | Kynam Capital Management, LP | 3,114,132 5.270% | 3,114,132 (New Position) | Filing |